Price controls threaten industry profits and promotional spendACA, American Health Care Act (AHCA), Biopharma, Congress, June 2017, Obamacare, Obamacare/Affordable Care Act (ACA), PhRMAWhatever comes out of Congress on the “repeal and replace” of the Affordable Care Act (ACA or Obamacare) matters because it will affect the bottom line of the life sciences industry as well as all of its industry partners. Read more June 9, 2017/by John Kamp https://www.pharmalive.com/wp-content/uploads/2015/06/KampJohn-official-photo.jpg 400 300 John Kamp https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png John Kamp2017-06-09 00:30:272017-06-15 13:56:40Price controls threaten industry profits and promotional spend